Similar articles

• Patients 65 years of age or older in cancer-treatment trials.

  Copur MS, Ledakis P, Muhvic J. Copur MS, et al. N Engl J Med. 2000 May 18;342(20):1531. N Engl J Med. 2000. PMID: 10819658 No abstract available.
• Cancer chemotherapy in elderly cancer patients.

  Balducci L. Balducci L. J Oncol Manag. 2005 Spring;14(2):35-8. J Oncol Manag. 2005. PMID: 16018197
• Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.

  Talarico L, Chen G, Pazdur R. Talarico L, et al. J Clin Oncol. 2004 Nov 15;22(22):4626-31. doi: 10.1200/JCO.2004.02.175. J Clin Oncol. 2004. PMID: 15542812
• [Discrimination of elderly patients in clinical research and health care].

  Werkö L. Werkö L. Lakartidningen. 2002 May 23;99(21):2414-6, 2419. Lakartidningen. 2002. PMID: 12090172 Review. Swedish. No abstract available.
• Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.

  Dale DC. Dale DC. J Support Oncol. 2003 Nov-Dec;1(4 Suppl 2):11-7. J Support Oncol. 2003. PMID: 15346995 Review.